Last reviewed · How we verify
NCT06177418
Transumbilical Laparoscopic Appendectomy
NA trial testing Transumbilical laparoscopic appendectomy + Glove finger technique in Appendicitis in 100 participants. Currently enrolling.
29 September 2024
Quick facts
| Lead sponsor | Necmi Kadıoğlu Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 25 December 2023 |
| Primary completion | 29 September 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Transumbilical laparoscopic appendectomy + Glove finger technique
- Standard transumbilical laparoscopic appendectomy
Conditions studied
- Appendicitis — all drugs for Appendicitis →
- Surgical Site Infection — all drugs for Surgical Site Infection →
Sponsor
Necmi Kadıoğlu Hospital
Who can join
Adults 5 to 18, any sex, with Appendicitis or Surgical Site Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Transumbilical laparoscopic appendectomy (TULA) is increasingly favored in the treatment of appendicitis within the realm of minimally invasive surgical approaches. This procedure offers advantages such as superior cosmetic outcomes and reduced postoperative pain. However, like all surgical interventions, it carries the inherent risk of surgical site infections (SSI), which pose significant challenges to patient health and healthcare systems by escalating treatment costs, prolonging recovery, and increasing morbidity rates. This study aims to evaluate the efficacy of the "glove finger method" in mitigating SSI risk in TULA. The rationale for this study is predicated on the hypothesis that the glove finger method could serve as a simple and cost-effective measure offering potential protection against SSIs. When compared to traditional methods, this technique may not only reduce surgical duration but also diminish the risk of SSIs, thereby potentially decreasing hospital stay durations. Furthermore, enhancing the understanding of factors contributing to the development of SSIs and developing effective strategies for their prevention can elevate patient care quality and alleviate the burden on healthcare systems.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06177418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Appendicitis
Currently open trials in the same condition.
- NCT07115303 — Results of Laparoscopic Appendectomy With Application of Clips Versus Ligature for Stump Closure · NA · recruiting
- NCT06395636 — Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients · NA · recruiting
- NCT07049965 — Comparative Study of Harmonic Scalpel vs. Suture Ligation for Appendix Base During Laparoscopic Appendectomy · NA · active not recruiting
- NCT07478029 — Clinical Study of PEG Bowel Preparation in Appendectomy Patients · recruiting
- NCT06083064 — Protocol Based Selective Imaging Versus Routine Computed Tomography or Ultrasound in Suspected Appendicitis · NA · recruiting
Other Necmi Kadıoğlu Hospital trials
Trials by the same sponsor.
- NCT06564740 — Stem Cell Applications in Biliary Atresia Patients · NA · recruiting
- NCT06324656 — The Efficacy of Combining Platelet-rich Plasma With Crystallized Phenol in Pilonidal Sinus Disease · NA · recruiting
- NCT06417060 — Caudal Anesthesia Versus Local Anesthesia in Hypospadias · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06177418 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Necmi Kadıoğlu Hospital
- Last refreshed: 20 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06177418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing